Continuing education in veterinary dermatology for 25 years !
News

Hypoallergenic Diets in Dogs and Cats: 2026 Update
Food allergy affects up to 33% of atopic dogs and 22% of pruritic cats. The elimination diet remains, in 2026, the only validated diagnostic tool for confirming food allergy, as no serological or salivary test can confirm it. Discover in this comprehensive article the immunopathological mechanisms and current diagnostic strategies, from the choice of hypoallergenic food to long-term management. Grain-free or insect-based diets, particularities of these diets in cats, the role of the provocation test, and much more.

Numelvi (Atinvicitinib) in Dogs: 2026 Monograph
Canine atopic dermatitis (CAD) affects 3 to 15% of the canine population. The arrival of atinvicitinib (NUMELVI, MSD Animal Health), a selective second-generation JAK1 inhibitor authorised in Europe in July 2025, has altered the therapeutic landscape of this condition. This review details updated data, from the molecular mechanism to management strategies.

Zenrelia (Ilunocitinib) in Dogs: 2026 Monograph
Canine atopic dermatitis affects 10 to 15% of the global canine population and constitutes one of the primary reasons for consultation in veterinary dermatology. In the face of this condition, new treatments are emerging with an excellent benefit/risk ratio. A comprehensive overview of Zenrelia (ilunocitinib), which is the first of the new Janus Kinase inhibitors to have been brought to market following oclacitinib (Apoquel).
Congress Report

Complete update on Malassezia in dogs and cats
Yeasts of the genus Malassezia constitute lipophilic fungal agents that have evolved as cutaneous commensals and opportunistic pathogens across various mammalian and avian species. Their involvement in canine and feline dermatological and otological conditions represents a daily clinical challenge for veterinary practitioners on a global scale. At the recent NAVDF congress in Orlando, our colleague Ross Bond, a world specialist on the subject, had the opportunity to provide a comprehensive update, covering pathogenic, diagnostic and therapeutic aspects.

Feline Sporotrichosis: Clinical Aspects and Epidemiology
On the occasion of the last NAVDF congress held in April in Orlando, our colleagues Drs. Flavia Clare and Clarissa Souza provided a comprehensive review of sporotrichosis, a rare and largely unknown fungal dermatosis.

Dermatoses of the nasal planum in dogs
Dermatoses of the canine nasal planum represent a unique diagnostic challenge for the veterinary practitioner, despite their relative frequency in dermatological consultations. The etiological diversity of these conditions, combined with the frequent overlap of clinical presentations, requires a rigorous methodical approach that our colleague Laura Ordeix presented at the last ESVD congress held in Bilbao, Spain.

2025 Update on the Etiopathogenesis of Canine Atopic Dermatitis
Canine atopic dermatitis represents a major clinical challenge in contemporary veterinary medicine, with a prevalence that continues to increase in urban canine populations. This chronic inflammatory skin condition, characterized by intense pruritus and recurrent cutaneous lesions, significantly affects the quality of life of animals and constitutes a frequent reason for consultation in veterinary dermatology. At the recent NAVDF congress in Orlando, our colleague Rosanna Marsella had the opportunity to provide a comprehensive 2025 update on the etiopathogenesis of Canine Atopic Dermatitis.

Canine cutaneous calcinosis: Etiologies and treatments
Cutaneous calcinoses represent a major diagnostic and therapeutic challenge in canine veterinary dermatology. These conditions, characterized by abnormal accumulation of calcium salts in dermal and hypodermal structures, require a rigorous clinical approach based on precise understanding of their distinct pathophysiological mechanisms.
Press review

Chronic otitis in dogs: Impact on quality of life
Chronic external otitis in dogs represents a frequent dermatological condition with a prevalence reaching 10.2% of veterinary clinical consultations. This inflammatory pathology of the auditory canal, often associated with underlying atopic dermatitis, generates considerable diagnostic and therapeutic challenges for practitioners.

Ultrasound-guided intralymphatic immunotherapy in canine atopic dermatitis: a retrospective study of 109 cases.
Canine atopic dermatitis (CAD) represents a major therapeutic challenge in veterinary dermatology, often requiring long-term management. Intralymphatic immunotherapy (ILIT) has progressively emerged as a promising alternative to conventional treatments, offering encouraging results in both human and veterinary medicine.

Allergy Testing and Immunotherapy in Atopic Cats
Intradermal allergy tests and specific allergen immunotherapy are still underutilized in the therapeutic management of feline dermatological conditions. This situation persists despite the demonstrated efficacy of these approaches in managing feline cutaneous atopic syndrome.

Immune-mediated skin disorders in cats: Part 2.
Feline immune-mediated skin diseases comprise a complex set of rare but potentially serious conditions that can mimic various infectious or allergic dermatoses. This second part of a series on immune-mediated dermatoses examines six distinct pathological entities characterized by specific pathophysiological mechanisms.
Review article

Update on Canine Dermatomyositis
Canine dermatomyositis (DM) is an inflammatory ischemic vasculopathy of immune origin with a strong genetic predisposition, primarily affecting the skin and, to a lesser extent, striated muscles. We present a comprehensive pathogenic, diagnostic, and therapeutic overview of this dermatosis.

Feline Cutaneous Herpes Viral Infection: Clinical and Therapeutic Aspects
Cutaneous viral dermatoses often remain underdiagnosed in cats, not only due to their relative rarity but also due to the inherent complexity in precisely identifying the causal agent.
